Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Suzanne Levine

Podiatrist, Foot Surgery New York, NY Doctor of Podiatric Medicine

NPI 1710037668 CMS profile 582895

885 Park Ave, Suite 103-105, New York, NY 10021

Open in the dashboard

General payments

$2,686

60 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Suzanne Levine of New York, NY is reported in the CMS Open Payments database as having received $2,686 across 60 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Podiatrist, Foot Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,500 1
2024 General $45 2
2022 General $120 1
2021 General $32 2
2020 General $589 28
2019 General $400 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Suzanne Levine
  • Podiatrist, Foot Surgery median
  • Middle half of Podiatrist, Foot Surgery
  • National median

In program year 2025, general payments to Suzanne Levine were reported at $1,500. Among 732 Podiatrist, Foot Surgery profiles paid that year, the median was $180 and the middle half received between $70 and $569.

Show as a table
Year Suzanne Levine Podiatrist, Foot Surgery median Middle half National median
2019 $400 $167 $67–$484 $163
2020 $589 $114 $40–$323 $114
2021 $32 $171 $57–$502 $132
2022 $120 $196 $66–$556 $149
2023 $0 $187 $78–$466 $160
2024 $45 $190 $78–$557 $164
2025 $1,500 $180 $70–$569 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Djo, LLC $1,500 1 payment
  2. Fidia Pharma USA Inc. $280 18 payments
  3. Zyla Life Sciences $274 18 payments
  4. ASSERTIO THERAPEUTICS, Inc. $189 9 payments
  5. Bioventus LLC $145 2 payments
  6. Musculoskeletal Transplant Foundation Inc. $119 1 payment
  7. Merck Sharp & Dohme Corporation $82 5 payments
  8. Horizon Therapeutics plc $48 3 payments
  9. Baudax Bio Inc. $36 2 payments
  10. Royal Biologics $12 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Debt forgiveness $1,500 1 payment
  2. Food and Beverage $1,186 59 payments
Products named General payments · program years 2019–2025
  1. SPRIX $274 18 payments
  2. NuDyn $203 14 payments
  3. ZIPSOR $189 9 payments
  4. SIVEXTRO $82 5 payments
  5. DUEXIS $48 3 payments
  6. ANJESO $36 2 payments
  7. Exogen $25 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

60 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record